I wonder why Aethlon Medical, Inc. (AEMD) is going downhill in the premarket?

AVGR Stock
AVGR Stock

Will we continue down this path, and if so, why? I suspect the NASDAQ-listed shares of Centennial Resource Development, Inc. might provide a clue to the answer. As of today, there have been no new developments with regards to the company, but it continues to fall consistently as Aethlon Medical, Inc. (Nasdaq: AEMD) shares drowned 6.73% to 2.08 in the premarket session.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


And all this shows me is that investors are all quite shaken up by Aethlon Medical, Inc. (Nasdaq: AEMD) news on December 16, 2020, that the first patient was treated in the Company’s first clinical Early Feasibility Trial testing HEMOPURIFIER in patients with chronic and/or metastatic head and neck squamous cell carcinoma.

Read More

The study is enrolling patients at UPMC Hillman Cancer Center in Pittsburgh, PA. Hemopurifier Plus Pembrolizumab in Head and Neck Cancer. I wondered whether all the anxiety was overblown.


Please enter your comment!
Please enter your name here